Prospective Evaluation of a New Covered Metal Stent for Malignant Lesions of the Esophagus

Withdrawn before enrolling · Phase 2

Conditions studied: Esophageal Cancer

In brief

In this study, a newly designed and FDA approved fully covered metal stents will be used to palliate 20 patients with malignant lesion of the esophagus. Dysphagia score will be assessed before and after treatment to confirm efficacy

Key facts

Study ID

NCT01301495

Run by

Weill Medical College of Cornell University

People needed

0

Starts

2010-11-01

Expected to finish

2013-11-01

Last updated by the study team

2015-06-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Inoperable malignant obstruction of the esophageal or gastric cardia
• Malignant fistula between the esophagus ans respiratory tree
• Recurrent cancer after prior radiation

You may not qualify if…

• Patient unstable for endoscopic procedure
• Previous esophageal stenting
• Tumor growth within 2 cm of the upper esophageal sphincter
• Pregnant women (self reported, no pregnancy test will be done per protocol)

Where it is running

• Weill Medical College of Cornell University — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.